Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS

Neurology. 2017 Aug 29;89(9):970-972. doi: 10.1212/WNL.0000000000004293. Epub 2017 Aug 2.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Fingolimod Hydrochloride / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Melanoma / complications
  • Melanoma / diagnosis
  • Melanoma / drug therapy*
  • Middle Aged
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Netherlands
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Fingolimod Hydrochloride